It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read MoreTop Stories
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Celebrating World Patient Safety Day 2024:
On World Patient Safety Day 2024, we focus on the critical...
Filter
Transforming Scientific Content with Microsoft 365 Copilot: Cactus Life Sciences in the Spotlight
We are thrilled to announce that Cactus Life Sciences has been featured in Microsoft Stories...
MedTech Summit 2021: Understanding Post Market Clinical Follow Up (PCMF)
An ideal PMCF plan, with reference to MDCG 2020-7, presents the general and specific methods...
Bringing New Devices to Market under the EU MDR
With the MDR coming into effect, the manufacturers should plan and construct their strategy to...
A Summarized Report of the Virtual MedTech EU MDR Exchange Conference
Session summaries from EUMDR exchange conference 2021...
Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?
Best practices to implement digital enhancements and measure effectiveness...
3 Factors That Will Help Pharma Build Public Trust
Pharma must engage with patients at all levels to build public trust...